Recombinant porcine somatotropin alters performance and carcass characteristics of heavyweight swine and swine fed alternative feedstuffs

The efficacy of recombinantly derived porcine somatotropin (rpST) in improving the performance and carcass characteristics of heavyweight finishing pigs was determined. In Study 1, 36 pigs were killed for determination of initial carcass composition at 102 kg, and 36 pigs each were given 0, 1.5, 3, 6, or 9 mg of rpST/d from 102 to 136 kg live weight. Corn-soybean meal diets fed contained 19.8% CP and greater than 1% lysine. Study 2 tested the effects of 3 mg/d on pigs for 4 wk from 84 kg BW fed a corn-soybean meal or a triticale-barley-peas diet. Performance variables (ADG, average daily feed intake [ADFI], and feed efficiency [FE]) were measured weekly. Treatment with rpST increased (P less than .01) ADG and FE and decreased (P less than .01) ADFI in both studies. In Study 1, leaf fat, backfat thickness, belly thickness, and carcass fat were all decreased (P less than .01) linearly by rpST. Loin eye area (LEA), total trimmed lean, and total protein content were increased quadratically (P less than .01). At the 3-mg dose, ADFI, ADG, and FE were 87, 130, and 137% of control, and LEA, backfat, total protein gain, and total fat gain were 107, 80, 136, and 52% of control. Loin eye area was not increased (P greater than .05) in the pigs in Study 2; however, backfat thickness was reduced 16% by rpST (P less than .01). The effects of rpST were the same on both dietary regimens (P greater than .05). These studies demonstrate the effectiveness of rpST in increasing ADG and carcass leanness and improving FE in heavyweight pigs and in pigs fed alternative feedstuffs.     

Effect of diet and exercise on performance, carcass traits and plasma components of growing-finishing barrows

Twenty-four barrows (approximately 25 kg initial wt) were used in each of three 2 X 2 factorially arranged trials to study effects of exercise (not exercised vs walking 30 min/d, 6 d/wk on a treadmill) and diet (low energy vs high energy) on performance during the growing-finishing period. Average daily gain (ADG) of barrows not exercised was greater (P less than .07) than that of those exercised. Barrows fed the high-energy diet had greater (P less than .05) ADG, lower (P less than .01) feed intake and lower (P less than .01) feed-to-gain ratio than barrows fed low-energy diets. In trials 1 and 2, pigs were slaughtered when removed from test and selected carcass measurements and internal organ weights were obtained. Exercise did not significantly affect carcass length, backfat thickness, loin muscle area or lean cuts (as a percentage of off-test weight). Pigs fed the high-energy diet had more (P less than .01) backfat than those fed the low-energy diet. Neither the exercise program nor the diet had a significant effect on organ weights. Pigs not exercised had a higher (P less than .05) plasma albumin-to-globulin ratio and lower (P less than .05) plasma creatinine concentration than did pigs that were exercised. Also, pigs not exercised had slightly higher (P less than .08) plasma albumin and glucose, but lower (P less than .06) plasma globulin levels.(ABSTRACT TRUNCATED AT 250 WORDS)     

Effect of pituitary somatotropin injections on plasma insulin-like growth factor I and somatotropin profiles in growing heifers

Effects of daily injections of pituitary-derived bovine somatotropin (bST) for 6 wk were evaluated in 10 growing heifers and compared to 9 placebo-treated control animals. Bovine somatotropin was injected at 50 micrograms/kg BW each day. Body weight and growth, plasma concentrations of insulin-like growth factor I (IGF-I) and somatotropin (ST) were assessed. To measure plasma concentrations of IGF-I, we validated a RIA in which bovine plasma samples were extracted with acid-ethanol, a method that resulted in greater than 90% recovery of IGF-I. Average daily gain was similar during the first 4 wk of the experiment in both control and bST-treated groups; however, at the end of the experimental period (wk 4 and 6) ADG was greater (P less than .05) in bST-treated heifers (1.24 +/- .21 kg/d vs .75 +/- .25 kg/d). Plasma IGF-I from wk 2 to wk 6 were increased in bST-treated animals (452 +/- 97 ng/ml at wk 2; 683 +/- 106 ng/ml at wk 6) compared with controls (293 +/- 62 ng/ml at wk 2 (P less than .01) and 293 +/- 115 ng/ml at wk 6 (P less than .001). Moreover, ADG over the 6-wk experimental period was correlated with mean IGF-I concentrations determined over the same period (r = .55; P less than .01). As expected, mean plasma ST concentrations were increased in bST-injected animals from wk 1 to 6. Gel chromatographic profiles of bovine plasma exhibit a 150,000 molecular weight ST-dependent binding protein-IGF-I complex and a 30,000 molecular weight non-ST-dependent complex. This study validates a method for measuring IGF-I in cattle, and shows a positive relationship among IGF-I and ADG after ST treatment. No correlation, however, was found between plasma ST and growth performance.     

Immune, growth and carcass responses of ram lambs to active immunization against desulfated cholecystokinin (CCK-8)

This study explored feed intake and carcass responses to active immunization against desulfated cholecystokinin-octapeptide (CCK-8) in ram lambs. Antibody titers 8 wk following primary immunization and booster immunizations given at 4 and 6 wk averaged greater than 1:1,000. Titers increased to greater than 1:10,000 by 16 wk following a final booster immunization at 11 wk. The antibodies developed against desulfated CCK-8 exhibited 29% and 13% cross-reactivities for sulfated CCK-8 and gastrin-17, respectively. Immunization against desulfated CCK-8 had no effect on feed intake, ADG, carcass weight or carcass quality grade. Backfat thickness and carcass yield grade were reduced (P less than .05) by immunization. Organ weights at slaughter, including those of the pancreas and small intestines, were not affected by CCK-8 immunization, with the exception of the lungs, which were 16% lighter (P less than .01) in immunized lambs. In conclusion, active immunization against desulfated CCK-8 resulted in development of high antibody titers against desulfated and sulfated CCK-8. Immunization against CCK-8 decreased fat content of the carcass but failed to affect feed intake, carcass weight or ADG.     

Growth and muscle development of feedlot cattle of different genetic backgrounds

The effects of crossbreeding, cattle type and dietary energy level on semitendinosus muscle (ST) development, feedlot performance, daily carcass protein and fat gain and serum anabolic hormone concentrations were studied. Over 3 consecutive years, 176 feedlot steers representing four cattle types - unselected Hereford (UH), selected Hereford (SH), Angus x Hereford x Charolais (AHC) and Angus x Hereford x Holstein (AHH) - were fed either an all-corn silage (HS) or a high grain (HG) diet. Steers were slaughtered on day 1 and at the end of the feedlot trial, and ST muscles were removed rapidly. During years 2 and 3, single blood samples were obtained from steers on days 1, 29, 57, 113 and 169, and analyzed for insulin and growth hormone (GH). Steers fed HG had a higher (P less than .005) average daily gain (ADG) than steers fed HS, and cattle type had an effect (P less than .005) on ADG. Cattle type and HG affected (P less than .005) daily carcass protein and fat gain. Weight of ST muscle and total muscle RNA, DNA and protein content increased with frame size, and HS steers had heavier (P less than .05) ST muscles than the HG steers. Steers fed HG had higher (P less than .01) serum insulin concentrations than steers fed HS, but there were no consistent cattle type effects. Serum GH concentrations were not affected by cattle type or diet. Serum insulin concentrations, combined across diet and cattle types, were correlated (P less than .01) with ADG; however, serum GH, assessed on the same basis, was not related to ADG. Average daily protein and fat gain were positively related to serum insulin and were negatively related to serum GH.     

Failure of photoperiod to alter body growth and carcass composition in beef steers

In each of two experiments, 70 crossbred steers were blocked by BW and assigned to initial slaughter groups or to treatments in a 2 x 2 design. In Exp. 1, treatments were 168 d of photoperiod (8 h of light [L]:16 h of dark [D] or 16L:8D) and plane of nutrition (high energy [HPN] or low energy [LPN]). On d -22, 67 and 155, blood was sampled every 20 min for 8 h. Relative to LPN, HPN increased (P less than .01) ADG by 28%, carcass weight by 26% and accretion of carcass fat by 109% and carcass protein by 20%. On d 155, compared with LPN, HPN increased (P less than .01) serum insulin (INS; 1.09 vs .64 ng/ml) and lowered (P less than .05) growth hormone (GH; 2.14 vs 3.70 ng/ml), but prolactin was not affected. Photoperiod did not affect BW gains, carcass composition or serum hormones. In Exp. 2, treatments were 113 d of photoperiod (8L:16D or 16L:8D) and Synovex-S implant (presence [IMP] or absence [NONIMP]). On d 93, blood was sampled every 30 min for 10 h. Relative to NONIMP, IMP increased (P less than .01) ADG by 12% and accretion of carcass protein by 16%. Implants did not affect carcass weight or accretion of fat. Compared with NONIMP, IMP increased (P less than .05) GH (3.16 vs 2.39 ng/ml) and INS (.68 vs .46 ng/ml) but did not affect PRL. Photoperiod did not affect BW gain, carcass composition or serum hormones. We conclude that photoperiod fails to influence growth and carcass composition of steers.     

The effect of zeranol on live weight gain, feed intake and carcass composition of steers during compensatory growth

To evaluate the effect of zeranol implants in steers on compensatory ++growth, 80 steer calves (9 mo of age; 200 kg) were fed at two feeding levels (RO = 9.2 MJ ME/kg DM; R1 = 6.9 MJ ME/kg DM) for 119 d (Period 1). During Period 2, steers were full-fed to 400 kg BW with (Z1) or without (ZO) zeranol implants. Ten steers were slaughtered at the end of Period 1 to estimate carcass composition. Differences of 100 kg in BW were achieved by restriction in Period 1. Subsequent to restriction, cumulative ADG remained greater (P less than .05) up to the 24th wk of recuperation and implants increased (P less than .001) BW gain by 31% and 24% for RO and R1, respectively. The average daily energy intake (ME/W(.75) in Period 2 was similar for all treatments. Feed conversion was improved by 21.5% (P less than .05) by implants. At the end of Period 2 the R1ZO had 8.6 kg less muscle (P less than .001), 2.9 kg less bone (P less than .001) and 5.9 kg more fat (P less than .05) than the ROZO. In comparison, the carcasses of the implanted animals did not show significant differences (P greater than .05) due to restriction. Carcass daily gains were increased by previous restriction (P less than .01) and implants (P less than .05). Zeranol increased daily live weight gain and feed conversion in animals in continuous growth as well as in those observed in compensatory growth an tended to eliminate a tendency for higher content of fat in carcasses of nonimplanted animals making compensatory growth.     

Effects of lysocellin and calcium level on mineral metabolism, performance and ruminal and plasma characteristics of beef steers

Metabolism and growth experiments were conducted to determine the effects of lysocellin and calcium level on mineral metabolism and performance of beef steers. Lysocellin at 0 or 22 mg/kg and Ca at .3 or .6% of the diet were fed in a 2 x 2 factorial arrangement of treatments. Two steers averaging 287 kg BW were fed each diet consisting of 80% corn silage and 20% supplement (DM basis) in each of two metabolism trials. Steers were fed the diets for a 21-d preliminary period, followed by 7 d of total feces and urine collection. A lysocellin x Ca interaction was observed for nitrogen retention (P less than .01). Steers fed lysocellin and .6% Ca retained the most N (15.6 g/d), whereas steers receiving lysocellin and .3% Ca retained the least N (8.8 g/d). Lysocellin increased (P less than .05) apparent absorption of Mg. In one of the two metabolism trials, lysocellin increased (P less than .05) apparent absorption and retention of Ca. Apparent absorption and retention of Ca were higher (P less than .05) in steers fed .6% Ca when expressed as grams per day, but absorption and retention were lower (P less than .01) when expressed as a percentage of intake. In the other metabolism trial, the .6% Ca level decreased (P less than .05) urinary P excretion and increased (P less than .05) P retention as a percentage of absorbed P. In a growth experiment, 64 steers were fed similar levels of lysocellin and Ca for 119 d. Diets consisted of 90% corn silage and 10% supplement. Although no treatment effects on ADG, DMI or feed:gain were detected, lysocellin did affect concentration of several minerals in ruminal fluid and blood plasma.     

Influence of zeranol and breed on growth, composition of gain, and plasma hormone concentrations

Seven Angus and six Brangus steers averaging 225 and 245 kg, respectively, were assigned randomly to zeranol (36 mg) implant (I) and no implant (NI) treatments. Steers had ad libitum access to a corn silage diet plus .68 kg of a soybean meal-based supplement fed daily. Steers were bled via jugular catheters on d 0, 28, 56, and 84 at 15-min intervals for 4 h before and 4 h after feeding. Concentrations of growth hormone (GH), insulin (INS), triiodothyronine (T3), thyroxine (T4), and glucose were determined. Whole-body protein and fat contents were monitored. A breed x I interaction (for d 56 to 84 and d 0 to 84) was observed for ADG (P less than .05 and P less than .07, respectively), feed conversion (P less than .05 and P less than .07, respectively), and protein deposition (for d 0 to 29 and d 0 to 84; P less than .07 and P less than .05, respectively). These interactions were attributed to a greater response to I by Angus than by Brangus steers. A feeding x period interaction (P less than .10) was observed for mean GH concentration, and INS, T4, and T3 concentrations were higher (P less than .05) during the 4-h postfeeding period than during the 4-h prefeeding period. The implant increased (P less than .08) mean GH concentration but did not alter the frequency, duration, or amplitude of plasma GH peaks. Steers that were implanted had lower (P less than .05) plasma T3. Brangus steers had lower (P less than .05) plasma glucose, T3, and T4 concentrations than Angus steers. Results indicate that growth factors beyond those measured are responsible for the anabolic response to zeranol.     

Effects of percentage Brahman and Angus breeding, age-season of feeding and slaughter end point on feedlot performance and carcass characteristics

Steers (n = 165) of known percentage Brahman (B) and Angus (A) breeding were used to study effects of breed group (A, 3/4A:1/4B, 1/2A:1/2B, 1/4A:3/4B), age-season of feeding (calves fed during the cool season vs yearlings fed during the warm season) and slaughter end point (less than .90, 1.0 to 1.15, 1.27 to 1.40, greater than or equal to 1.5 cm of adjusted fat over the ribeye) on feedlot performance and carcass characteristics. The 1/2B and 3/4B steers had heavier (P less than .05) initial and final feedlot weights than the A and 1/4B steers and higher (P less than .05) unshrunk ADG than the A steers did. Breed types did not differ for feed efficiency. Yearling steers fed in the warm season had higher (P less than .05) unshrunk ADG than calves fed in the cool season, but ADG calculated on an empty-rumen basis did not differ between the two age-seasons of feeding. Calves fed in the cool season were more efficient (P less than .05) than yearlings fed in the warm season when efficiency was expressed on an empty-rumen basis; however, on a live weight basis there was no difference in feed efficiency. No breed group by age-season of feeding interactions on performance were detected. Slaughter end point did not significantly affect feed efficiency on an empty-rumen basis. The 1/2B and 3/4B steers had smaller ribeye areas (REA) per 100 kg hot carcass and lower marbling scores than the 1/4B and A steers. Yearlings fed in the warm season produced heavier carcasses (P less than .05) than calves fed in the cool season. As s.c. fat thickness at slaughter increased, hot carcass weight and numerical yield grade increased, whereas REA per 100 kg of hot carcass decreased. Marbling also increased as fatness increased up to about 1.5 cm subcutaneous fat.     

Effect of vitamin E and copper on the vitamin E status and performance of growing pigs

A 13-wk trial was conducted with 32 pigs to determine the effects of dietary Cu (250 ppm) and alpha-tocopheryl acetate (ATA, 22 IU/kg) on the performance, serum enzymes, serum and tissue tocopherols, and antibody production in growing pigs. Pigs were fed corn-soybean meal diets containing 21% CP the first 4 wk and 18% CP during the rest of the trial. All feed was stored a minimum of 14 d before it was fed. The addition of Cu decreased (P less than .01) the concentration of alpha-tocopherol in the feed. alpha-Tocopherol concentrations were less than .01 mg/kg in the starter diet and less than 2 mg/kg in the grower diet after 14 d of storage. Supplemental Cu or ATA had no effect on ADG, feed intake, or gain:feed during the first 4 wk. During wk 5 to 13, the addition of Cu to diets containing no ATA increased daily feed intake and decreased gain:feed, but with ATA addition, feed intake decreased and gain:feed increased, resulting in a Cu x ATA interaction (P less than .05). The addition of Cu or ATA had no effect (P greater than .1) on serum glutathione peroxidase or lactic dehydrogenase activity. Serum tocopherols were reduced (P less than .05) by the addition of Cu during wk 1 to 4, 6 (P less than .01), and 7 (P less than .05) and increased (P less than .01) by ATA addition during the entire experiment. The addition of ATA increased the tocopherol concentrations in bile, ham, heart, pancreas, kidney, spleen, liver, psoas and longissimus muscle (P less than .01), kidney fat, backfat, and adrenal gland (P less than .05).(ABSTRACT TRUNCATED AT 250 WORDS)     

Effects of placing cattle on feed at two-month intervals and housing on feedlot performance and carcass grades

A 5-yr study was conducted involving the placement of yearling steers on feed at 2-mo intervals under three different housing systems. A total of 3,571 steers (180 pens) initially averaging 318 kg was used. Evaluations were made for DM intake, ADG, feed efficiency (FE), carcass quality (QG), and yield grades (YG). Cattle were assigned to either an open lot with overhead shelter (S), an open lot without overhead shelter (NS), or an open-front confinement building (C). Each treatment consisted of two lots of 20 steers each per interval per trial. Corn grain provided 85% of the energy; the remainder was supplied by corn silage and protein supplement. Cattle were fed 140 to 180 d to achieve an average slaughter weight of 500 kg. The main effects of year (Y), month (M), and housing (H) affected DM intake, ADG, FE, and final live weight (P less than .01). The interactions for Y x M, M x H and Y x M x H affected ADG (P less than .05). Month and H affected hot carcass weight (P less than .01). Year affected YG, and year and month affected QG (P less than .01). Month effects on DM intake and ADG indicated that cattle started in May had the highest intake and ADG (P less than .05) and that cattle started in November had the lowest (P less than .05) DMI and ADG. Month effects on FE indicated that cattle were most efficient when placed on feed during March, May, and July (5.82, 5.72, and 5.66 kg DM/kg gain; P less than .05).(ABSTRACT TRUNCATED AT 250 WORDS)     

Exogenous human growth hormone-releasing factor and ovine somatotropin improve growth performance and composition of gain in lambs

The objectives of this study were 1) to compare intermittent subcutaneous administration of human growth hormone-releasing factor (hGRF) at two doses with a similar regimen of ovine somatotropin (oST) for effects on growth and composition of gain in growing lambs and 2) to determine whether increasing the dietary amino acid availability enhances response to oST or hGRF. Eighty crossbred ewe and wether lambs (25.5 kg live weight) were assigned randomly in pairs to receive four daily injections of excipient, 40 micrograms oST/kg BW, 5 micrograms hGRF/kg BW or 10 micrograms hGRF/kg BW for 42 (n = 80) or 56 (n = 40) d. Doses were adjusted weekly for BW. Mean plasma oST concentrations increased from 2.03 ng/ml prior to treatment to 20.64, 4.80 and 5.45 ng/ml with oST, 5 and 10 micrograms/kg hGRF doses, respectively. Lambs did not become refractory to hGRF. Cumulative gain increased approximately 18% with 7 wk of treatment with oST and the low dose of hGRF (both P less than .01), and feed efficiency improved 21% with oST and 18% with both doses of hGRF (both P less than .05). Carcass lipid accretion rate decreased 22% to 30% (P less than .001), and carcass protein accretion rate increased 30% to 36% (P less than .001) with hGRF and oST treatment, respectively. Addition of fishmeal to the diet at 4% to replace an equal amount of soy protein improved gain 8.5%; it improved efficiency 14.2% (P less than .05) across all treatments, and it significantly enhanced the effects of oST on feed efficiency (interaction P less than .12) and hind leg muscle weights.     

Evidence that bovine growth hormone treatment increases the rate of extrathyroidal 5'-monodeiodinase activity in cattle

This study examined the influence of bovine growth hormone (bGH) on liver and kidney thyroxine-5'-monodeiodinase activity (TMA) in growing beef cattle. In a preliminary trial (trial 1), tissue samples were obtained at slaughter from two placebo-injected and two bGH-injected (29.2 IU/day for 14 days before slaughter) Hereford heifers (398 kg avg slaughter wt), with one heifer on each treatment fed at either 1.0 or 2.0 times maintenance energy requirement. In a second trial, tissue and plasma samples were obtained from six placebo-injected and six bGH-injected (29.2 IU/day for 19 days) Hereford steers (331 kg avg slaughter wt) fed at 1.8 times maintenance energy requirement. In a third trial, liver tissue and plasma samples were obtained from 14 Angus X Hereford steers (270 kg avg wt) fed either an 8% protein, 1.96 Mcal-metabolizable energy/kg diet (8 steers) or a 14% protein, 2.67 Mcal-metabolizable energy/kg diet (6 steers) in association with acute administration of bGH. Half the steers in each group were given two injections per steer of either placebo or 37.8 IU bGH at 24-hr intervals and slaughtered 24 hr after the second injection. Units of tissue TMA in all trials were measured at slaughter; one unit defined as 1 ng T3 generated/hr/mg protein during incubation with T4 (1.3 fM). In trial 1, TMA in liver and kidney was 2.86 and 1.21 times greater, respectively, for bGH than for placebo treatments. In trial 2, units of TMA in liver homogenates were higher (P less than .05) for bGH (4.14) than for placebo (2.83) treatments and higher (P less than .02) in liver microsomal preparations for bGH (32.7) than for placebo (27.3) treatments. Units of TMA in kidney homogenates were also higher (P less than .10) for bGH (1.48) than for placebo (.87) treatments and higher (P less than .02) in kidney microsomal preparations for bGH (23.0) than for placebo (16.4) treatments. Following acute injection of bGH (trial 3), units of TMA in liver homogenates were higher (P less than .01) for bGH (2.5) than for placebo (1.8) treatments. Plasma T4 (70.0 vs 73.5 ng/ml) and T3 (1.08 vs 1.18 ng/ml) concentrations appeared slightly higher in bGH-treated steers (trial 2) and increased by 20 and .5 ng/ml, respectively, (P less than .01) within 6 to 12 h after acute injection of bGH (trial 3). Concurrently, plasma TSH concentration increased following acute GH injection (trial 3).(ABSTRACT TRUNCATED AT 400 WORDS)     

Influence of diet on basal and growth hormone-stimulated plasma concentrations of IGF-I in beef cattle

The effects of nutrition on plasma concentrations of insulin-like growth factor-I (IGF-I) were characterized in steers under basal conditions and following single i.m. injection of bovine growth hormone (bGH, .1 mg/kg BW). Nutritional effects on IGF-I were studied in three trials. In all trials steers were individually fed and penned Angus or Hereford x Angus (280 kg). In the first trial, two diets (LPLE1: 8% CP and 1.96 Mcal ME/kg, 4.5 kg.hd-1.d-1; MPHE1: 11% CP, 2.67 Mcal ME/kg, 6.5 kg.hd-1.d-1) were fed (n = 5/diet). Plasma IGF-I concentrations averaged 74 (LPLE1) and 152 (MPHE1) ng/ml (P less than .02). Following bGH injection, IGF-I increased to peak concentrations between 12 and 24 h (averaging 105 and 208 ng/ml at peak for LPLE and MPLE, respectively, P less than .01). In the second trial, steers were fed diets composed of 8, 11 or 14% CP and 1.96 or 2.67 Mcal ME/kg dry matter (6.35 kg.hd-1.d-1 in a factorial arrangement for 84 d, n = 4/diet). Within the low ME diet groups, plasma IGF-I was similar in steers fed 11 and 14% CP but greater at these two CP levels than in steers fed 8% CP (P less than .05). Within the high ME diet groups, plasma IGF-I increased linearly with CP (P less than .01). In the third trial, steers were fed diets to result in a negative N status. Insulin-like growth factor-I was lower (P less than .02) during feed restriction than when steers were full-fed. The IGF-I response to bGH was diminished or absent in underfed steers (P less than .01). These data are interpreted to suggest that diet composition and intake affect plasma concentrations of IGF-I in steers. In cattle, CP may be the primary nutritional determinant of basal IGF-I, but the IGF-I response to CP may be affected by the available ME. Undernutrition can attenuate the IGF-I response to GH and uncouple the regulation of IGF-I normally ascribed to GH.     

Effects of implants on daily gains of steers wintered on dormant native tallgrass prairie, subsequent performance, and carcass characteristics

Fall-weaned crossbred steer calves (n = 300; 184 +/- 2.9 kg) received either no implant (Control) or were implanted with Synovex-C (SC = 10 mg estradiol benzoate + 100 mg progesterone), Synovex-S (SS = 20 mg estradiol benzoate + 200 mg progesterone), or Revalor-G (RG = 8 mg estradiol-17beta + 40 mg trenbolone acetate) to determine the effects of implants on weight gain during winter grazing on dormant tallgrass prairie, subsequent grazing and finishing performance, and carcass characteristics. Steers grazed two dormant tallgrass prairie pastures from October 16, 1996, until March 29, 1997 (164 d), and received 1.36 kg/d of a 25% CP supplement that supplied 100 mg of monensin/steer. Following winter grazing, all steers were implanted with Ralgro (36 mg zeranol) and grazed a common tallgrass prairie pasture until July 17 (110 d). After summer grazing, all steers were implanted with Revalor-S (24 mg estradiol-17beta + 120 mg trenbolone acetate), and winter implant treatment groups were equally allotted to four feedlot pens. Steers were harvested November 17, 1997, after a 123-d finishing period. Daily gains during the winter grazing phase averaged .28, .32, .32, or .35 kg/d, respectively, for Control, SC, SS, or RG steers and were greater (P < .01) for implanted steers than for Controls. Summer daily gains were similar (1.05 +/- .016 kg/d; P > or = .61) for all treatment groups. Feedlot daily gains were also similar (1.67 +/- .034 kg/d; P > or = .21), with implanted steers weighing 14 kg more than Control steers (P = .05) at harvest, despite similar management during summer grazing and feedlot phases. Control steers tended (P = .06) to have lower yield grades. There were no differences (P = .99) in marbling between implanted and nonimplanted steers. Steers implanted during the wintering phase had increased skeletal and overall (P < .01) carcass maturities compared with nonimplanted steers, which resulted in more "B" and "C" maturity carcasses. Because carcass maturity score affects quality grade, the increased maturities of implanted steers resulted in a $9.04 decrease in carcass value/100 kg (P < .01) compared with Controls. The results of this study indicate that growth-promoting implants are efficacious for cattle wintered on dormant native range despite low daily gains. This increased weight is maintained through the summer grazing and feedlot phases; however, the benefit of the increased weight may be offset by decreased carcass quality grade and value due to increased carcass maturity.     

Effects of ractopamine, genotype, and growth phase on finishing performance and carcass value in swine: I. Growth performance and carcass merit

A replicated factorial experiment using 183 individually fed crossbred barrows was conducted. Pigs were fed an 18.5% CP (.95% lysine) diet with 3,594 kcal of ME/kg. The effects of five genotypes (GT): 1) Hampshire (H) x (H x Duroc [D]), 2) synthetic terminal sire line, 3) (H x D) x (Landrace [L] x [Yorkshire (Y) x D]), 4) L x (Y x D), and 5) Y x L; two levels of ractopamine (RAC) treatment: 0 and 20 ppm; and three treatment weight periods (WT): 1) 59 to 100, 2) 73 to 114, and 3) 86 to 127 kg live weight on growth performance and carcass traits were evaluated. Ractopamine increased (P less than .0001) amount (FSL) and percentage (PFSL) of carcass lean standardized to 10% fat content, loin eye area (LEA), and dressing percentage (PDRES) and reduced (P less than .01) amount (DF) and percentage (PDF) of dissected fat. Magnitudes of RAC effects were smaller than those reported by other researchers. Effects of GT and WT on all growth and carcass traits were highly significant (P less than .001) except for those of WT on ADG (P less than .05) and GT on average feed intake (AFI) and backfat thickness at the last rib (BFLR; P less than .05). Genotype 3 performed better for most economically important traits than did GT 1 and 4, suggesting that heterosis existed in GT 3, which essentially was obtained by crossing GT 1 and 4. Among the three treatment periods, WT 2 had the highest ADG. As BW increased from WT 1 to 3, AFI and AFI/ADG ratio (FCR) increased and lean percentage decreased.(ABSTRACT TRUNCATED AT 250 WORDS)     

The effects of bovine growth hormone and thyroxine on growth rate and carcass measurements in lambs

The effects of bovine growth hormone (GH) and thyroxine (T4) on growth and carcass characteristics were assessed in Dorset ram lambs. Lambs in four groups (n = 10/group) were treated for 30 d as follows: controls, 3.33 mg (6 IU) GH/d (s.c.); 5-mg T4 implant (s.c.) on d 1 and a 10-mg T4 implant 21 d later; GH + T4. Blood samples were collected at 3-d intervals for analysis of GH, T4, triiodothyronine, somatomedin-C and testosterone concentrations. Six lambs/group were slaughtered for carcass measurements and composition. Daily GH injections increased (P less than .005) baseline plasma GH levels 10-fold, whereas plasma T4 concentrations were increased 10% (P less than .10) by the implants. Somatomedin-C increased with time in all groups, but the increments from d 0 to d 30 were higher (P less than .05) with GH treatment. Average daily gain (mean = 352 g/d), feed consumption and feed to gain ratio were not affected (P greater than .1) by GH or T4 treatment in ram lambs. Hot carcass weight and dressing percentage were increased (P less than .05) by T4. Growth hormone increased carcass protein content (P less than .005) and muscle weights while reducing carcass fat (P less than .05). Carcass composition was not altered by T4 alone, and the T4 x GH interaction was not significant; however, the combination of T4 and GH resulted in greater muscle and protein weight than did either hormone alone or no hormone administration. There were no differences in bone length or in the metacarpal growth plate width among groups. The beneficial effects of GH on carcass composition were not further enhanced by administration of thyroxine.     

Effect of monensin, estradiol controlled release implants and supplement on performance in grazing steers

Five trials in five locations in the United States involving 512 steers were conducted to evaluate the effect of monensin [200 mg/d in .9 kg of supplement (Ru mensin )] and estradiol-controlled release implants ( Compudose ) administered alone and in combination on average daily gain (ADG) in steers on pasture. The effect of energy supplementation on rate of gain was also evaluated in these same trials. The initial weight of steers averaged 250 kg and the average duration of the five trials was 124 d. Estradiol-controlled release implants increased ADG by 15.6% (.095 kg/d; P less than .0001) and monensin increased ADG by 8.1% (.054 kg/d; P less than .05). The combination of estradiol-controlled release implant and monensin increased ADG by 27.4% (.168 kg/d). Treatment responses were additive relative to ADG response, with no interaction observed between the treatments. Nine-tenths kilograms of an energy supplement/d increased ADG by 12.4% (.073 kg/d; P less than .01).     

Growth and carcass characteristics of pigs selected for fast or slow gain in relation to feed intake and efficiency.

Selection in pigs for either fast (line F) or slow (line S) postweaning gain was replicated in spring (SREP) and fall (FREP) farrowing groups. Littermate barrows were sampled from F and S during Generations 2, 3, and 4 of the SREP and Generation 3 of the FREP. Beginning at approximately 35 kg (OTWT), barrows were either allowed ad libitum access to feed (AL) or limited to a standard total feed intake (LIM). Blocks of the line x intake level factorial were removed from test and carcass data collected when the average weight of barrows in the block was approximately 110 kg. Carcass data were also collected on an additional barrow from each litter at OTWT to allow estimation of lean tissue gain per unit of feed consumed (LTFC) of tested barrows. In Generations 3 and 4 of the SREP, F-AL was greater (P less than .01) than S-AL for average daily intake and ADG; carcass backfat was greater (P less than .01) but LTFC tended to be less (P less than .10) for F-AL than for S-AL. When LIM was imposed in the SREP, F barrows gained faster (P less than .05) than S barrows in Generation 4, but across generation the lines did not differ for carcass backfat and LTFC was greater (P less than .01) for F than for S. In the FREP, F-AL was greater (P less than .05) than S-AL for average daily intake and ADG and was less (P less than .05) for LTFC, but F and S did not differ for these traits when LIM was imposed; carcass backfat of F was greater (P less than .01) than that of S by .46 cm under AL and .38 cm under LIM. Most of the response in ADG could be attributed to changes in intake, but results in Generation 4 of the SREP indicated that changes in efficiency had also contributed. Most of the additional intake in F vs S resulted in deposition of fat, probably due in part to the heavier weight of F-AL vs S-AL barrows.